関連する実験動画

Updated: Jan 7, 2026

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice
08:50

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice

Published on: October 18, 2024

948

肥満,不糖症のマウスの心代謝結果に対するケトゲンダイエット介入の影響

Cassandra A A Locatelli1,2, My-Anh Nguyen1,2, Nadya M Morrow1,2

  • 1Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, The University of Ottawa, 451 Smyth Road, room 4103, ON, K1H 8M5, Ottawa, Canada.

Cardiovascular diabetology
|January 4, 2026
PubMed
まとめ

No abstract available in PubMed .

キーワード:
動脈硬化症コレステロールグルカゴンのようなペプチド1-炎症島々ケトゲンダイエットステアトーシス

さらに関連する動画

Assessment of the Metabolic Effects of Isocaloric 2:1 Intermittent Fasting in Mice08:06

Assessment of the Metabolic Effects of Isocaloric 2:1 Intermittent Fasting in Mice

Published on: November 27, 2019

9.4K
Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

71.2K

関連する概念動画

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
218